Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer

Conditions:   Stage III Pancreatic Cancer AJCC v8;   Stage IV Pancreatic Cancer AJCC v8;   Unresectable Pancreatic Carcinoma Interventions:   Drug: Bosentan;   Drug: Gemcitabine;   Drug: Nab-paclitaxel;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration Sponsors:   City of Hope Medical Center;   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials